As resistance grows, treating severe malaria in African children becomes more challenging. Hence, new guidelines and treatment strategies are needed to combat this devastating mosquito-borne disease. Artemisinin Partial Resistance in Ugandan Children With Complicated Malaria - (https://jamanetwork.com/journals/jama/fullarticle/2826317)

10 patients who were thought to have been cured suffered a repeat malaria attack within 28 days from the same strain of malaria that caused the original infection, researchers found.

Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalized for complicated malaria, according to a new study presented at the Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH).

The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with mosquito-borne malaria.

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally,